[68Ga]Ga-FAPI-46: Clinical Trials

4 trials of [68Ga]Ga-FAPI-46, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 4

Follow [68Ga]Ga-FAPI-46: new trials by email Literature Review of [68Ga]Ga-FAPI-46 trials Research Report on [68Ga]Ga-FAPI-46

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis
[68Ga]Ga-FAPI-46 - Transthyretin Cardiac Amyloidosis
Phase 2RecruitingNantes University Hospital402026-09-092026-09-14
Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer
[68Ga]Ga-FAPI-46 - Carcinoma, Intraductal, Noninfiltrating
Phase 2RecruitingUniversität Münster302026-02-202026-06-03
[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
[68Ga]Ga-FAPI-46 - Malignant Melanoma Stage IV
Phase 2RecruitingBarbara Malene Fischer202025-08-152025-10-10
BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
[68Ga]Ga-FAPI-46 - Pancreatic Cancer, Adult, Gastroesophageal Cancer (GC)
Phase 2RecruitingBarbara Malene Fischer902024-01-162026-06-05

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Carcinoma, Signet Ring Cell (1)  ·  Melanoma (1)  ·  Pancreatic Neoplasms (1)  ·  Pancreatic cancer, adult (1)

Sponsors

Barbara Malene Fischer (2)  ·  Nantes University Hospital (1)  ·  Universität Münster (1)

Countries

Denmark (2)  ·  France (1)  ·  Germany (1)

Top investigators

Philipp Backhaus, Dr. med. (1)

NIH funding

2023 (3), 2025 (1)